2nd Victory for Xarelto Defendants
2nd Victory for Xarelto Defendants
Introduction
The jury for a second time, consecutively, ruled in favor of the defendants, J&J and Bayer, in the Xarelto Lawsuit trial. The defendant came in strong, stating that the death of the plaintiff was caused due to several other underlying conditions and not Xarelto. This verdict has further strengthened the manufacturer's count and would require a thorough preparation by the plaintiffs and their legal aid in the upcoming lawsuits. The next hearing is scheduled for this August, in Mississippi.
Comments
Latest News
Teen E-cigarette Use Hits 10-Year Low
Categories: E-Cigarette: JUUL
Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…
Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m
Categories: Opioids
The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…
Drug Distributors Reach $300M Opioid Settlement
Categories: Opioids
The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…